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SUPPLEMENTARY INFORMATION 
Supplementary Materials & Methods 
2.7 One-dimensional electrophoresis and Western blotting 
Exosomal proteins were solubilized in lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 
1 mM EGTA, 1% Triton X, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4, 1 
µg/ml leupeptin), including protease inhibitors, for subsequent Western blot analysis. To extract cellular 
proteins, T24, FL3 and SLT4 cells were harvested, washed twice with ice-cold PBS, and solubilized in lysis 
buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton X, 2.5 mM sodium 
pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3VO4, 1 µg/ml leupeptin) to which complete Mini 
protease inhibitor cocktail, PhosSTOP phosphatase inhibitor cocktail (both from Roche) and 2.0 mM 
Pefabloc (Sigma-Aldrich, St Louis, MO, USA) was added immediately before use, on ice for 30 min. Cell 
lysates were centrifuged at 10,000 × g at 4 °C to remove cellular debris. Protein in the exosome and cell 
lysates was quantified using Bradford microassays (Bio-Rad, Hercules, CA, USA). Cell lysate and exosome 
samples were suspended in sample buffer (2% SDS, 10% glycerol, 50 mM Tris-HCl pH 6.8, bromophenol 
blue) and subjected to denaturing electrophoresis using precast Novex 4-12% or 12% Bis–Tris NuPAGE gels 
(Invitrogen, Carlsbad, CA, USA) in MOPS running buffer at constant 150 V for 70 min. Proteins were 
electrotransferred onto Immobilon PVDF membranes (Millipore, MA, USA), and the membranes blocked 
with 5% (w/v) skim milk powder in PBS with 0.1% (v/v) Tween-20 (PBST) for 1 h at RT. The Western blots 
were visualized using ECL Prime agents (Amersham Biosciences, Buckinghamshire, UK) and imaged on a 
ChemiDoc-It Imaging Sytem (Bio-Rad, Hercules, CA, USA). Signals were quantified by densitometry using 
ImageJ 1.46r software (National Institutes of Health, Bethesda, Maryland, USA). 
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2.11 Bioinformatic analysis 
The lists of significantly up- and downregulated proteins (>1.5 or <0.67 iTRAQ ratios, in at least two out of 
three replicates, respectively) in metastatic exosomes versus non-metastatic exosomes were analyzed 
through the use of IPA (Ingenuity® Systems,  http://www.ingenuity.com). For IPA, the Core Analysis module 
was used to rank the proteins into biological, molecular and cellular functions. The analysis settings and 
parameters for IPA was as follows: (i) Reference set, Ingenuity Knowledge Base (Genes Only); (ii) 
Relationship to include, Direct and Indirect; (iii) Filter Summary, Consider only molecules and/or 
relationships where (species=Human) AND (confidence = Experimentally observed OR High (predicted)) 
AND (cell lines = All Cancer cell lines in ingenuity database). Student´s t-test, Fisher´s exact test with 
Benjamini-Hochberg correction, and spearman correlation were used to test statistical significance where 
indicated. 
 
 
Supplementary figure legends 
Supplementary Figure S1. (A) Analysis of the isogenic relationship in between the cell lines used by STR 
analysis. (B) Phase contrast pictures of T24 and FL3 cells grown in conventional cell culture flasks (top) and 
explanted cells after 6 weeks of culturing in CELLine Adhere 1000 Culture System bioreactor (bottom). 
 
Supplementary Table S1. Data files displaying all proteins in biological replicate sample 1 detected with at 
least two unique peptides, and divided into separate MEMBRANE and LUMEN sheets. UNIPROT Accession, 
protein name, peptides identified, coverage, and further details are listed. 
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Supplementary Table S2. Data files displaying all proteins in biological replicate sample 2 detected with at 
least two unique peptides, and divided into separate MEMBRANE and LUMEN sheets. UNIPROT Accession, 
protein name, peptides identified, coverage, and further details are listed. 
 
Supplementary Table S3. List of proteins with significant increased or decreased expression in exosomes 
from metastatic FL3 cells versus non-metastatic T24 cells. The list contains membrane and luminal proteins 
identified from quantitative iTRAQ proteomics that meet the following criteria: (i) Protein detected in 
exosomes from both FL3 and T24 cells, ii) the protein identification was made with at least two unique 
peptides, iii) the ratio of the protein abundance for metastatic FL3 exosomes to non-metastatic T24 
exosomes was >1.5 fold or <0.67 with a variability of less than 50 % and (iv) the fold changes in abundance 
was observed in a second independent biological replicate that also met criteria (i) to (iii).  
 
Supplementary Table S4. List of proteins with significant increased or decreased expression in exosomes 
from metastatic SLT4 cells versus non-metastatic T24 cells. The list contains membrane and luminal 
proteins identified from quantitative iTRAQ proteomics that meet the following criteria: (i) Protein detected 
in exosomes from both SLT4 and T24 cells, ii) the protein identification was made with at least two unique 
peptides, iii) the ratio of the protein abundance for metastatic SLT4 exosomes to non-metastatic T24 
exosomes was >1.5 fold or <0.67 with a variability of less than 50 % and (iii) the fold changes in abundance 
was observed in a second independent biological replicate that also met criteria (i) to (iii). 
 
Supplementary Figure S2. IPA pathway maps generated from lists of proteins with significantly altered 
abundance (>1.5 fold or <0.67 fold) in the top scoring networks for exosomes from metastatic FL3 (Fisher’s 
exact test, P = 1×10-44) and SLT4 (P = 1×10-39) cells compared to non-metastatic T24 cells. 
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